For patients with negative axillary lymph node ultrasound findings, the number of mast cells and BTG2 expression levels in tumor tissue can be assessed to determine whether additional radiotherapy is needed to improve the immune suppression in micrometastatic lymph nodes. Here, BTG2 is linked to neoplasm.